Novartis' Sandoz founds new initiative to expand biosimilar use more globally

[cafead]

via Sandoz on Tuesday launched a new initiative called “Act4Biosimilars,” led by a steering committee that includes Sandoz exec Michael Wiechmann, the company’s global head of medical affairs.

article source